PubRank

Stephen Rennard

Author PubWeight™ 61.52‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Susceptibility to exacerbation in chronic obstructive pulmonary disease. N Engl J Med 2010 15.07
2 Six-minute-walk test in chronic obstructive pulmonary disease: minimal clinically important difference for death or hospitalization. Am J Respir Crit Care Med 2012 3.44
3 Smoking cessation with varenicline, a selective alpha4beta2 nicotinic receptor partial agonist: results from a 7-week, randomized, placebo- and bupropion-controlled trial with 1-year follow-up. Arch Intern Med 2006 3.30
4 Efficacy and safety of the novel selective nicotinic acetylcholine receptor partial agonist, varenicline, for smoking cessation. Arch Intern Med 2006 3.30
5 Safety and immunogenicity of a nicotine conjugate vaccine in current smokers. Clin Pharmacol Ther 2005 2.04
6 Design of the Subpopulations and Intermediate Outcomes in COPD Study (SPIROMICS). Thorax 2013 1.99
7 Inflammatory biomarkers improve clinical prediction of mortality in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2012 1.99
8 A genome-wide association study of COPD identifies a susceptibility locus on chromosome 19q13. Hum Mol Genet 2011 1.98
9 Effects of sustained-release bupropion among persons interested in reducing but not quitting smoking. Am J Med 2004 1.76
10 Genome-wide association analysis of blood biomarkers in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2012 1.72
11 Bronchodilator responsiveness as a phenotypic characteristic of established chronic obstructive pulmonary disease. Thorax 2012 1.72
12 Chronic obstructive pulmonary disease biomarker(s) for disease activity needed--urgently. Am J Respir Crit Care Med 2010 1.66
13 COPD as a lung disease with systemic consequences--clinical impact, mechanisms, and potential for early intervention. COPD 2008 1.65
14 Gender differences in the management and experience of Chronic Obstructive Pulmonary Disease. Respir Med 2004 1.37
15 Predicting outcomes from 6-minute walk distance in chronic obstructive pulmonary disease. J Am Med Dir Assoc 2011 1.28
16 Variable DNA methylation is associated with chronic obstructive pulmonary disease and lung function. Am J Respir Crit Care Med 2011 1.26
17 Sputum neutrophils as a biomarker in COPD: findings from the ECLIPSE study. Respir Res 2010 1.26
18 Shotgun proteomic analysis of human-induced sputum. Proteomics 2006 1.16
19 A randomised trial of fluticasone furoate/vilanterol (50/25 μg; 100/25 μg) on lung function in COPD. Respir Med 2013 1.12
20 Determinants of airflow obstruction in severe alpha-1-antitrypsin deficiency. Thorax 2007 1.12
21 Genetics of sputum gene expression in chronic obstructive pulmonary disease. PLoS One 2011 1.11
22 The COPD Biomarker Qualification Consortium (CBQC). COPD 2013 1.06
23 Inflammation in COPD: implications for management. Am J Med 2012 1.00
24 NF-kappaB mediates the survival of human bronchial epithelial cells exposed to cigarette smoke extract. Respir Res 2008 0.96
25 Identification of lipocalin and apolipoprotein A1 as biomarkers of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2010 0.94
26 Diet and vitamin D as risk factors for lung impairment and COPD. Transl Res 2013 0.94
27 One-year treatment with mometasone furoate in chronic obstructive pulmonary disease. Respir Res 2008 0.89
28 One-year extension study of ACCORD COPD I: safety and efficacy of two doses of twice-daily aclidinium bromide in patients with COPD. COPD 2013 0.88
29 The association of plasma biomarkers with computed tomography-assessed emphysema phenotypes. Respir Res 2014 0.88
30 Vitamin D, vitamin D binding protein, lung function and structure in COPD. Respir Med 2013 0.84
31 Turning a molecule into a medicine: the development of indacaterol as a novel once-daily bronchodilator treatment for patients with COPD. Drugs 2014 0.82
32 Using COPD multidimensional indices in routine clinical practice: DOSE meets all criteria. Prim Care Respir J 2012 0.81
33 Analyzing networks of phenotypes in complex diseases: methodology and applications in COPD. BMC Syst Biol 2014 0.80
34 Response of vitamin D binding protein and free vitamin D concentrations to vitamin D supplementation in hospitalized premature infants. J Pediatr Endocrinol Metab 2015 0.76
35 Development of a primary-care tool to assess treatment success in COPD: consensus report from a closed meeting of respiratory and primary-care specialists. Prim Care Respir J 2004 0.75
36 It's about time--directing our attention toward modifying the course of COPD. Respir Med 2008 0.75